No abstract available
Publication types
-
Guideline
-
Practice Guideline
MeSH terms
-
Abnormalities, Drug-Induced / etiology
-
Acetates / therapeutic use
-
Administration, Inhalation
-
Administration, Intranasal
-
Administration, Oral
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / adverse effects
-
Adrenergic beta-Agonists / therapeutic use
-
Albuterol / analogs & derivatives
-
Albuterol / therapeutic use
-
Animals
-
Anti-Allergic Agents / therapeutic use*
-
Anti-Asthmatic Agents / therapeutic use*
-
Asthma / drug therapy*
-
Budesonide / administration & dosage
-
Chlorpheniramine / therapeutic use
-
Cyclopropanes
-
Ephedrine / administration & dosage
-
Female
-
Histamine H1 Antagonists / therapeutic use
-
Humans
-
Hydroxyurea / analogs & derivatives
-
Hydroxyurea / therapeutic use
-
Hypersensitivity / drug therapy*
-
Indoles
-
Ipratropium / administration & dosage
-
Leukotriene Antagonists / therapeutic use
-
Metaproterenol / therapeutic use
-
Nasal Decongestants / administration & dosage
-
Nebulizers and Vaporizers
-
Nedocromil / administration & dosage
-
Phenylcarbamates
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Pregnancy Complications / immunology*
-
Quinolines / therapeutic use
-
Salmeterol Xinafoate
-
Sulfides
-
Sulfonamides
-
Terbutaline / therapeutic use
-
Tosyl Compounds / therapeutic use
-
Tripelennamine / therapeutic use
Substances
-
Acetates
-
Adrenal Cortex Hormones
-
Adrenergic beta-Agonists
-
Anti-Allergic Agents
-
Anti-Asthmatic Agents
-
Cyclopropanes
-
Histamine H1 Antagonists
-
Indoles
-
Leukotriene Antagonists
-
Nasal Decongestants
-
Phenylcarbamates
-
Quinolines
-
Sulfides
-
Sulfonamides
-
Tosyl Compounds
-
Nedocromil
-
Tripelennamine
-
Chlorpheniramine
-
Budesonide
-
Metaproterenol
-
Salmeterol Xinafoate
-
Ephedrine
-
Ipratropium
-
montelukast
-
Terbutaline
-
Albuterol
-
zileuton
-
Hydroxyurea
-
zafirlukast